Literature DB >> 8699569

[A study on survival rates of oral squamous cell carcinoma].

G S Chen1, C H Chen.   

Abstract

Oral squamous cell carcinoma is seen predominantly after the fourth decade of life. We have retrospectively reviewed 103 patients (92 males and 11 females) with squamous cell carcinoma, which were confirmed by histopathologic examination and treated by surgical excision at Kaohsiung Medical College Hospital from 1987 to 1991. The age of the patients ranged from 23 to 87 years. 39.8% of cases occurred on the buccal mucosa, 27.2% on the tongue, 15.5% on the gingiva of mandible, 8% on the maxilla, 7.8% on the lower lip and 1% on the floor of the mouth. 23.3% of the patients had stage I disease, 14.6% were stage II, 43.7% were stage III and 18.4% stage IV. Of 103 patients treated with wide excision, about 65% (17/103) of patients treated with wide excision and radical neck dissection or suprahyoid neck dissection, and 41% (42/103) were treated by a combination of radiation and surgery. 96% (99/103) of our cases have completed a minimum follow-up period of 3 years. The sex and age of the patients did not influence survival significantly. The 5-year survival rates were 62% for patients with stage I disease, 80% for patients with stage II disease, 42% for patients with stage III, and 19% for patients with stage IV disease. Stage at initial presentation was an important factor influencing survival. The location of the primary tumor did not significantly influence survival for early stage tumors (stage I & II). In terminal stage tumors (stage III & IV). those with carcinomas of the floor of the mouth, gingiva of the mandible, lip, and maxilla had a 5-year survival of 15%, those with carcinomas of the tongue had a 5-year survival of 47%, and those with carcinomas of the buccal mucosa had a favorable survival rate of 53%. The differences were significant (P = 0.017).

Entities:  

Mesh:

Year:  1996        PMID: 8699569

Source DB:  PubMed          Journal:  Kaohsiung J Med Sci        ISSN: 1607-551X            Impact factor:   2.744


  6 in total

1.  CYP1A1 MspI polymorphism and the risk of oral squamous cell carcinoma: Evidence from a meta-analysis.

Authors:  Shang Xie; Chongdai Luo; Xiaofeng Shan; Shushan Zhao; Jing He; Zhigang Cai
Journal:  Mol Clin Oncol       Date:  2016-02-05

2.  A YAP/TAZ-Regulated Molecular Signature Is Associated with Oral Squamous Cell Carcinoma.

Authors:  Samantha E Hiemer; Liye Zhang; Vinay K Kartha; Trevor S Packer; Munirah Almershed; Vikki Noonan; Maria Kukuruzinska; Manish V Bais; Stefano Monti; Xaralabos Varelas
Journal:  Mol Cancer Res       Date:  2015-03-20       Impact factor: 5.852

3.  Clinicopathological and prognostic significance of survivin expression in patients with oral squamous cell carcinoma: evidence from a meta-analysis.

Authors:  Shang Xie; Hui Xu; Xiaofeng Shan; Baozhong Liu; Kan Wang; Zhigang Cai
Journal:  PLoS One       Date:  2015-02-24       Impact factor: 3.240

4.  What is the Prognostic Significance of Ki-67 Positivity in Oral Squamous Cell Carcinoma?

Authors:  Shang Xie; Ying Liu; Xue Qiao; Rui-Xi Hua; Kan Wang; Xiao-Feng Shan; Zhi-Gang Cai
Journal:  J Cancer       Date:  2016-04-10       Impact factor: 4.207

5.  Association between CYP1A1 Ile462Val Polymorphism and Oral Squamous Cell Carcinoma Susceptibility: Evidence from 13 Investigations.

Authors:  Xiao-Lei Yang; Shang Xie; Yi-Yan Jiang; Chang Shi; Zhi-Gang Cai; Su-Xiu Chen
Journal:  J Cancer       Date:  2015-01-22       Impact factor: 4.207

6.  YM155 Down-Regulates Survivin and Induces P53 Up-Regulated Modulator of Apoptosis (PUMA)-Dependent in Oral Squamous Cell Carcinoma Cells.

Authors:  Xiang Yan; Han Su
Journal:  Med Sci Monit       Date:  2017-04-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.